BioSpace News Archive

Accelerate Diagnostics, Inc. announced that Louise Francesconi has been appointed to the company’s Board of Directors.

Practice Management Tools Provide Access to Workflow and Image Quality Analytics to Help Improve Mammographic Quality and Maximize Resource Utilization.

Bracco Diagnostics Inc. announced that its contrast agent LUMASON is the first ultrasound enhancing agent to obtain U.S. Food and Drug Administration approval for use in echocardiography to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border in pediatric patients with suboptimal echocardiograms.

Versiti, Inc., a national leader in blood health innovation, is excited to announce the launch of its new P-Selectin Expression Assay.

Apollo Endosurgery, Inc. announced that company management will present at the 12th Annual LD Micro Main Event investor conference at the Luxe Sunset Boulevard Hotel in Los Angeles, California, on Tuesday, December 10, 2019.

Presentations to include safety and efficacy outcomes for patients treated with brain-responsive neuromodulation

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body’s immune system in the fight against cancer, today announced that data from its ongoing studies utilizing Cchek™, its artificial intelligence (AI) driven early cancer detection technology will be presented during a poster session at the San Antonio Breast Cancer Symposium (SABCS).

Company reinforces breast health leadership with innovative new products, breakthrough Artificial Intelligence-powered platform and prestigious IMV ranking

Piper Jaffray 31st Annual Healthcare Conference on Wednesday, December 4, 2019 at 9:30-9:50 am ET at the Lotte New York Palace.

Both Swiss companies agreed to collaborate in the field of personalized multifocal soft contact lenses for presbyopia correction.